Physician profile
Onitisha Anders
NPI 1801158761
$639.79
in general payments reported to CMS, 2019-2025
13 companies · $92.81 in 2025
The $92.81 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.24 · 2022: $151 · 2023: $127 · 2024: $230 · 2025: $92.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $140.54 | 2021-2024 | |
| Ferring Pharmaceuticals INC. | $95.63 | 2021-2023 | Menopur |
| Abbott Laboratories | $57.37 | 2024 | Proclaim |
| Novo Nordisk INC | $53.36 | 2024-2025 | Wegovy |
| Boston Scientific Corporation | $51.35 | 2024 | Wavewriter Alpha Prime 16 |
| Gilead Sciences, INC. | $47.23 | 2023-2024 | Epclusa |
| Merck Sharp & Dohme LLC | $47.20 | 2023-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Exact Sciences Corporation | $38.08 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $37.36 | 2024-2025 | |
| Organon LLC | $20.90 | 2025 | Nexplanon |
| Emd Serono, INC. | $18.95 | 2022 | |
| Hologic Sales and Service, LLC | $16.49 | 2024 | Omni Hysteroscope |
| Amgen INC. | $15.33 | 2024 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Onitisha Anders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.